Phosphate Therapeutics Alternatives & Competitors

12 companies similar to Phosphate Therapeutics — Advancing mineral-derived hospital pharmaceuticals for critical renal disease tr...

Shield Therapeutics plc

Helping patients become people again

71 Post-IPO Debt $33.20M

United Kingdom

Biotechnology Health and Wellness +1

Cavion

Empowering therapies for cancer and neurologic diseases through pioneering ion channel inh...

Series A $31.10M

Biotechnology Health Care +1

Trimel Pharmaceuticals

Pioneering innovative solutions for male hypogonadism, female sexual dysfunction, and resp...

Post-IPO Equity $72.45M

Biotechnology Health Care

TransPharma Medical

Pioneering transdermal drug delivery to enhance therapeutic outcomes for osteoporosis and...

Series C $33.40M

Biotechnology Health Care +1

Track all Phosphate Therapeutics competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Tribute Pharmaceuticals Canada

Dedicated to advancing healthcare in Canada with proven pharmaceuticals and a commitment t...

Post-IPO Equity $38.00M

Biotechnology Health Care +1

Lassen Therapeutics

Combining innovative science, leading technology, and unmatched know-how to create novel m...

11 Series B $116.00M

San Diego, United States

Biotechnology Health Care +2

Amyl Therapeutics

Restoring clarity in amyloid diseases

11 Grant $29.70M

Liege, Belgium

Biotechnology Health Care +1

Cara Therapeutics

Transforming the way pruritus is treated to bring quality to the lives of those who suffer

46 Post-IPO Debt $517.20M

Stamford, United States

Biotechnology Health Care +1

ASCEND THERAPEUTICS U.S., LLC

Morristown, United States

Biotechnology Health and Wellness +1

Orexo AB publ

Improves lives for patients suffering from mental illness and substance use disorder 💚

97 Post-IPO Debt $571.60M

Sweden

Biotechnology Health Care +1

Booster Therapeutics

Pioneering proteasome therapeutics for a new approach to complex disease

Berlin, Germany

Biotechnology Health and Wellness

NeRRe Therapeutics Ltd

Developing a breakthrough treatment for the disabling chronic cough associated with idiopa...

9 Series B $61.40M

Stevenage, United Kingdom

Biotechnology Health Care

About Phosphate Therapeutics

Phosphate Therapeutics, based in the UK, is an independent specialty pharmaceutical firm dedicated to developing hospital pharmaceuticals derived from minerals. The company plans to utilize the funding to finalize Phase 2 development of its phosphate binder (PT20) aimed at treating late-stage renal disease patients suf...

Business keywords

Pharmaceuticals, Mineral-derived, Renal Disease Treatment, Phosphate Binder, Hyperphosphataemia, Medical Research Council, Specialty Pharmaceuticals, Phase 2 Development, UK-based Company

Frequently Asked Questions

Companies similar to Phosphate Therapeutics include Shield Therapeutics plc, Cavion, Trimel Pharmaceuticals, TransPharma Medical, Tribute Pharmaceuticals Canada. They work in Biotechnology and Health Care and share Phosphate Therapeutics's focus on pharmaceuticals, specialty pharmaceuticals and uk-based company.

Bounce Watch lists 12 companies that share Phosphate Therapeutics's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Phosphate Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Phosphate Therapeutics Profile Cavion Alternatives TransPharma Medical Alternatives Tribute Pharmaceuticals Canada Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Phosphate Therapeutics on 12 Sep 2024. The 12 companies listed here were last checked between 19 Jun 2024 and 13 Apr 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.